Related Experiment Videos
Review article: drug-induced hepatotoxicity
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8887.
Alimentary Pharmacology & Therapeutics
|October 1, 1993
Summary
The liver metabolizes drugs, but some can cause rare liver injury through toxic byproducts. Understanding these mechanisms is key to managing drug-induced hepatotoxicity, especially with new medications.
Area of Science:
- Hepatology
- Toxicology
- Pharmacology
Background:
- The liver is crucial for metabolizing drugs and foreign substances (xenobiotics).
- Most substances are processed without causing liver damage.
- Some compounds, like acetaminophen, cause predictable liver injury, while others cause rare hepatotoxicity under specific conditions.
Purpose of the Study:
- To review mechanisms of drug-induced liver injury (hepatotoxicity).
- To discuss factors influencing toxic metabolite accumulation.
- To highlight emerging issues in drug-induced hepatotoxicity.
Main Methods:
- Review of clinical examples of metabolic reactions leading to liver injury.
- Discussion of new challenges in drug-induced hepatotoxicity.
- Analysis of factors promoting toxin accumulation in hepatocytes.
Main Results:
- Toxic metabolites generated in hepatocytes can cause direct cell injury or indirect immune-mediated damage.
- Factors like genetic variations, enzyme induction, and substrate competition can increase toxin accumulation.
- New drug-induced hepatotoxicity risks emerge with novel compounds, combination therapies, and alternative health products.
Conclusions:
- Drug-induced hepatotoxicity can result from direct cellular damage or immune responses.
- Understanding metabolic pathways and factors influencing toxin levels is vital for preventing liver injury.
- Caution is advised with new drugs until their safety profile is well-established.